John T. Treace, Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 45,670 shares at $16.99 ($776K) on 2021-12-28, disclosed to the SEC on 2021-12-30.
Open-market sale of $776k TMCI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.99 | 19,760 | $336K | 43.3% |
| 2 | $16.99 | 19,760 | $336K | 43.3% |
| 3 | $17.01 | 3,075 | $52K | 6.7% |
| 4 | $17.01 | 3,075 | $52K | 6.7% |
| Total | $16.99 avg | 45,670 | $776K | 100% |
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |